PKS21004
CAS: 2095521-90-5
Ref. 3D-VID52190
5mg | To inquire | ||
10mg | To inquire | ||
25mg | To inquire | ||
50mg | To inquire | ||
100mg | To inquire |
Product Information
PKS21004 is a noncompetitive inhibitor of the immunoproteasome that binds to the catalytic subunit. It has been shown to be effective in the treatment of infectious diseases, autoimmune diseases, and cancer. The drug targets the proteasome by binding to the catalytic subunit, which inhibits its function and prevents protein degradation. PKS21004 also induces apoptotic cell death in cells with high levels of immunoproteasomes. This drug has been shown to be effective in treating inflammatory diseases.
Chemical properties
Technical inquiry about: 3D-VID52190 PKS21004
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.